SCHEMBL5066593

SCHEMBL5066593

Cc1ccc(OS(=O)(=O)O)c(N)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
CYP3A4 P08684 2/20 0.55
CA1 P00915 4/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 2/20 0.50
ALOX15 P16050 2/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 2/20 0.43
TP53 P04637 1/20 0.43
THRB P10828 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.41
CA5A P35218 1/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
MMP13 P45452 1/20 0.39
CHEK1 O14757 1/20 0.39
SLC6A4 P31645 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30311551 1.00 ALDH1A1 (0.55) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL11490908 0.85 CA1 (0.50) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL14872867 0.83 ALDH1A1 (0.57) ALDH1A1CYP3A4CA1CA2CA9
Sulfuric Acid SCHEMBL10957580 0.81 ALDH1A1 (0.78) ALDH1A1CYP3A4CA1CA2CA9
SCHEMBL5691182 0.81 ALDH1A1 (0.46) ALDH1A1CYP3A4CA1CA2ALOX15
SCHEMBL4131406 0.81 CA1 (0.48) CA1CA2CA9TDP1TP53
SCHEMBL7766505 0.79 CISD1 (0.41) ALDH1A1CA1CA2CA9HSD17B10
SCHEMBL5202114 0.79 CA1 (0.52) ALDH1A1CA1CA2CA9ALOX15
SCHEMBL7755552 0.79 GLA (0.44) ALDH1A1CA1CA2CA9THRB
SCHEMBL15443118 0.79 CYP1A2 (0.56) ALDH1A1CYP3A4CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM UNIV CALIFORNIA (US) 2025-12-11 US disclosed
US-20080274920-A1 Reducing friction between two moving surfaces; oil additive mixture FUJIFILM CORPORATION (JP) 2008-11-06 US disclosed
WO-2004012656-A2 THIOPHENE AND FURAN DERIVATIVES AS PROSTAGLANDIN AGONISTS AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2004-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM CYP27A1, LIPC, CYP46A1 ALDH1A1 1661/4885CYP3A4 832/4885CA1 2438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.